These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 8057469)

  • 21. Inhibition of HIV-LTR gene expression by oligonucleotides targeted to the TAR element.
    Vickers T; Baker BF; Cook PD; Zounes M; Buckheit RW; Germany J; Ecker DJ
    Nucleic Acids Res; 1991 Jun; 19(12):3359-68. PubMed ID: 2062653
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Functional analysis of the complex trans-activating response element RNA structure in simian immunodeficiency virus.
    Centlivre M; Klaver B; Berkhout B; Das AT
    J Virol; 2008 Sep; 82(18):9171-8. PubMed ID: 18596090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G.
    Jeeninga RE; Hoogenkamp M; Armand-Ugon M; de Baar M; Verhoef K; Berkhout B
    J Virol; 2000 Apr; 74(8):3740-51. PubMed ID: 10729149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The TAR hairpin of human immunodeficiency virus type 1 can be deleted when not required for Tat-mediated activation of transcription.
    Das AT; Harwig A; Vrolijk MM; Berkhout B
    J Virol; 2007 Jul; 81(14):7742-8. PubMed ID: 17494072
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequence-specific interaction of Tat protein and Tat peptides with the transactivation-responsive sequence element of human immunodeficiency virus type 1 in vitro.
    Cordingley MG; LaFemina RL; Callahan PL; Condra JH; Sardana VV; Graham DJ; Nguyen TM; LeGrow K; Gotlib L; Schlabach AJ
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8985-9. PubMed ID: 2247474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of YB-1 with human immunodeficiency virus type 1 Tat and TAR RNA modulates viral promoter activity.
    Ansari SA; Safak M; Gallia GL; Sawaya BE; Amini S; Khalili K
    J Gen Virol; 1999 Oct; 80 ( Pt 10)():2629-2638. PubMed ID: 10573156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
    Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
    J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of HIV-1 replication by anti-trans-activation responsive polyamide nucleotide analog.
    Kaushik N; Basu A; Pandey VN
    Antiviral Res; 2002 Oct; 56(1):13-27. PubMed ID: 12323396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orientation-specific cis complementation by bulge- and loop-mutated human immunodeficiency virus type 1 TAR RNAs.
    Braddock M; Powell R; Sutton J; Kingsman AJ; Kingsman SM
    J Virol; 1994 Dec; 68(12):8396-400. PubMed ID: 7966633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Replication of human immunodeficiency viruses engineered with heterologous Tat-transactivation response element interactions.
    Xie B; Wainberg MA; Frankel AD
    J Virol; 2003 Feb; 77(3):1984-91. PubMed ID: 12525632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aromatic polyamidines inhibiting the Tat-induced HIV-1 transcription recognize structured TAR-RNA.
    Mischiati C; Jeang KT; Feriotto G; Breda L; Borgatti M; Bianchi N; Gambari R
    Antisense Nucleic Acid Drug Dev; 2001 Aug; 11(4):209-17. PubMed ID: 11572598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolution of a disrupted TAR RNA hairpin structure in the HIV-1 virus.
    Klaver B; Berkhout B
    EMBO J; 1994 Jun; 13(11):2650-9. PubMed ID: 8013464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimal Tat-mediated activation of the HIV-1 LTR promoter requires a full-length TAR RNA hairpin.
    Verhoef K; Tijms M; Berkhout B
    Nucleic Acids Res; 1997 Feb; 25(3):496-502. PubMed ID: 9016587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAR loop-dependent human immunodeficiency virus trans activation requires factors encoded on human chromosome 12.
    Hart CE; Galphin JC; Westhafer MA; Schochetman G
    J Virol; 1993 Aug; 67(8):5020-4. PubMed ID: 8331737
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of Tat-mediated transactivation of HIV-1 LTR transcription by polyamide nucleic acid targeted to TAR hairpin element.
    Mayhood T; Kaushik N; Pandey PK; Kashanchi F; Deng L; Pandey VN
    Biochemistry; 2000 Sep; 39(38):11532-9. PubMed ID: 10995220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of HIV-1 in CEM cells by a potent TAR decoy.
    Lee SW; Gallardo HF; Gaspar O; Smith C; Gilboa E
    Gene Ther; 1995 Aug; 2(6):377-84. PubMed ID: 7584112
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter.
    Biswas DK; Salas TR; Wang F; Ahlers CM; Dezube BJ; Pardee AB
    J Virol; 1995 Dec; 69(12):7437-44. PubMed ID: 7494249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An intact TAR element and cytoplasmic localization are necessary for efficient packaging of human immunodeficiency virus type 1 genomic RNA.
    Helga-Maria C; Hammarskjöld ML; Rekosh D
    J Virol; 1999 May; 73(5):4127-35. PubMed ID: 10196309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Requirement for HIV-1 TAR sequences for Tat activation in rodent cells.
    Sutton JA; Braddock M; Kingsman AJ; Kingsman SM
    Virology; 1995 Jan; 206(1):690-4. PubMed ID: 7530399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.